

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cholesterol transport (GO:0032375) | 6.61182952 |
| 2 | negative regulation of sterol transport (GO:0032372) | 6.61182952 |
| 3 | regulation of protein activation cascade (GO:2000257) | 6.44177991 |
| 4 | regulation of fibrinolysis (GO:0051917) | 6.36296151 |
| 5 | negative regulation of fibrinolysis (GO:0051918) | 6.28419926 |
| 6 | regulation of complement activation (GO:0030449) | 6.23752062 |
| 7 | peptidyl-glutamic acid carboxylation (GO:0017187) | 6.12693267 |
| 8 | protein carboxylation (GO:0018214) | 6.12693267 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.08305625 |
| 10 | epoxygenase P450 pathway (GO:0019373) | 5.95269186 |
| 11 | complement activation, alternative pathway (GO:0006957) | 5.93795105 |
| 12 | response to mercury ion (GO:0046689) | 5.91977917 |
| 13 | high-density lipoprotein particle remodeling (GO:0034375) | 5.83399471 |
| 14 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.68809062 |
| 15 | L-phenylalanine catabolic process (GO:0006559) | 5.68809062 |
| 16 | protein-lipid complex remodeling (GO:0034368) | 5.63620870 |
| 17 | macromolecular complex remodeling (GO:0034367) | 5.63620870 |
| 18 | plasma lipoprotein particle remodeling (GO:0034369) | 5.63620870 |
| 19 | regulation of cholesterol esterification (GO:0010872) | 5.52898062 |
| 20 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.38981951 |
| 21 | plasma lipoprotein particle assembly (GO:0034377) | 5.36636717 |
| 22 | cholesterol efflux (GO:0033344) | 5.33528819 |
| 23 | phospholipid efflux (GO:0033700) | 5.32994942 |
| 24 | reverse cholesterol transport (GO:0043691) | 5.29052792 |
| 25 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.27721799 |
| 26 | L-phenylalanine metabolic process (GO:0006558) | 5.27721799 |
| 27 | drug catabolic process (GO:0042737) | 5.10295388 |
| 28 | glyoxylate metabolic process (GO:0046487) | 5.07150300 |
| 29 | intestinal cholesterol absorption (GO:0030299) | 5.05088120 |
| 30 | regulation of plasminogen activation (GO:0010755) | 5.01992275 |
| 31 | blood coagulation, intrinsic pathway (GO:0007597) | 4.99143555 |
| 32 | ethanol oxidation (GO:0006069) | 4.84545970 |
| 33 | exogenous drug catabolic process (GO:0042738) | 4.81840602 |
| 34 | protein-lipid complex assembly (GO:0065005) | 4.76424249 |
| 35 | omega-hydroxylase P450 pathway (GO:0097267) | 4.75950051 |
| 36 | plasma lipoprotein particle organization (GO:0071827) | 4.70677634 |
| 37 | regulation of triglyceride catabolic process (GO:0010896) | 4.69805151 |
| 38 | fibrinolysis (GO:0042730) | 4.44554748 |
| 39 | protein-lipid complex subunit organization (GO:0071825) | 4.41831989 |
| 40 | triglyceride homeostasis (GO:0070328) | 4.41298529 |
| 41 | acylglycerol homeostasis (GO:0055090) | 4.41298529 |
| 42 | drug metabolic process (GO:0017144) | 4.36690337 |
| 43 | low-density lipoprotein particle remodeling (GO:0034374) | 4.28236249 |
| 44 | negative regulation of protein activation cascade (GO:2000258) | 4.25716057 |
| 45 | aromatic amino acid family catabolic process (GO:0009074) | 4.21868228 |
| 46 | cellular glucuronidation (GO:0052695) | 4.18797198 |
| 47 | plasma lipoprotein particle clearance (GO:0034381) | 4.15445327 |
| 48 | negative regulation of lipase activity (GO:0060192) | 4.15008970 |
| 49 | urate metabolic process (GO:0046415) | 4.14553136 |
| 50 | urea metabolic process (GO:0019627) | 4.12562556 |
| 51 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.12213264 |
| 52 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.12213264 |
| 53 | protein activation cascade (GO:0072376) | 4.11320203 |
| 54 | negative regulation of hemostasis (GO:1900047) | 4.02185331 |
| 55 | negative regulation of blood coagulation (GO:0030195) | 4.02185331 |
| 56 | intestinal absorption (GO:0050892) | 4.02158345 |
| 57 | lipoprotein metabolic process (GO:0042157) | 4.01703926 |
| 58 | acute-phase response (GO:0006953) | 3.98145536 |
| 59 | glutamate metabolic process (GO:0006536) | 3.97519436 |
| 60 | serine family amino acid catabolic process (GO:0009071) | 3.97326277 |
| 61 | glucuronate metabolic process (GO:0019585) | 3.96442189 |
| 62 | uronic acid metabolic process (GO:0006063) | 3.96442189 |
| 63 | flavonoid metabolic process (GO:0009812) | 3.96422520 |
| 64 | amino-acid betaine metabolic process (GO:0006577) | 3.90553243 |
| 65 | complement activation, classical pathway (GO:0006958) | 3.90172406 |
| 66 | ethanol metabolic process (GO:0006067) | 3.87636954 |
| 67 | excretion (GO:0007588) | 3.85672490 |
| 68 | regulation of apoptotic cell clearance (GO:2000425) | 3.82367623 |
| 69 | regulation of bile acid biosynthetic process (GO:0070857) | 3.81085371 |
| 70 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.79898750 |
| 71 | urea cycle (GO:0000050) | 3.76371300 |
| 72 | bile acid metabolic process (GO:0008206) | 3.75918765 |
| 73 | negative regulation of coagulation (GO:0050819) | 3.73318601 |
| 74 | cholesterol homeostasis (GO:0042632) | 3.72832082 |
| 75 | imidazole-containing compound metabolic process (GO:0052803) | 3.69628624 |
| 76 | regulation of humoral immune response (GO:0002920) | 3.67957313 |
| 77 | sterol homeostasis (GO:0055092) | 3.67271620 |
| 78 | polyol transport (GO:0015791) | 3.66667266 |
| 79 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.65361717 |
| 80 | nitrogen cycle metabolic process (GO:0071941) | 3.64563829 |
| 81 | complement activation (GO:0006956) | 3.61569480 |
| 82 | negative regulation of wound healing (GO:0061045) | 3.57362371 |
| 83 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.56465305 |
| 84 | negative regulation of complement activation (GO:0045916) | 3.52284082 |
| 85 | bile acid biosynthetic process (GO:0006699) | 3.51384932 |
| 86 | drug transmembrane transport (GO:0006855) | 3.50984848 |
| 87 | proline metabolic process (GO:0006560) | 3.43913173 |
| 88 | phosphate ion homeostasis (GO:0055062) | 3.40702943 |
| 89 | trivalent inorganic anion homeostasis (GO:0072506) | 3.40702943 |
| 90 | sterol transport (GO:0015918) | 3.40547691 |
| 91 | cholesterol transport (GO:0030301) | 3.40547691 |
| 92 | phenylpropanoid metabolic process (GO:0009698) | 3.40404777 |
| 93 | bile acid and bile salt transport (GO:0015721) | 3.39800197 |
| 94 | S-adenosylmethionine metabolic process (GO:0046500) | 3.39513250 |
| 95 | diacylglycerol metabolic process (GO:0046339) | 3.39281906 |
| 96 | negative regulation of lipid transport (GO:0032369) | 3.38638812 |
| 97 | glycine metabolic process (GO:0006544) | 3.31997192 |
| 98 | positive regulation of lipid catabolic process (GO:0050996) | 3.31972025 |
| 99 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.24260383 |
| 100 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.22458178 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.79343757 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.35800795 |
| 3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.57656683 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.56980244 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.53527501 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.59869090 |
| 7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.21090075 |
| 8 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.89700503 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.74581832 |
| 10 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.67124934 |
| 11 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.50062908 |
| 12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.41480974 |
| 13 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 2.40220968 |
| 14 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.23199708 |
| 15 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.01251363 |
| 16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.89310140 |
| 17 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.86312001 |
| 18 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.70905538 |
| 19 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.59967569 |
| 20 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.52560567 |
| 21 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.50393107 |
| 22 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.50377765 |
| 23 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.48005328 |
| 24 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.41188190 |
| 25 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.39366872 |
| 26 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.38994994 |
| 27 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.38444254 |
| 28 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.30874425 |
| 29 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.28785787 |
| 30 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.26632009 |
| 31 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.24144657 |
| 32 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.20809783 |
| 33 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.14801291 |
| 34 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.10133317 |
| 35 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.09750050 |
| 36 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.09136036 |
| 37 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.08554513 |
| 38 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.07874190 |
| 39 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.07435799 |
| 40 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.05718162 |
| 41 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.04340084 |
| 42 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.02039980 |
| 43 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.00508912 |
| 44 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.95971569 |
| 45 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.95408102 |
| 46 | RXR_22108803_ChIP-Seq_LS180_Human | 0.93798602 |
| 47 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.92998825 |
| 48 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.91468362 |
| 49 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.90830199 |
| 50 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.88590593 |
| 51 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.88330104 |
| 52 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.87631043 |
| 53 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.87440106 |
| 54 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.85501976 |
| 55 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.85465471 |
| 56 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.85102389 |
| 57 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.84577931 |
| 58 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.83564197 |
| 59 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.82277933 |
| 60 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.80046590 |
| 61 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.79618817 |
| 62 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.79356907 |
| 63 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.78978001 |
| 64 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.78358852 |
| 65 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.78018745 |
| 66 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.77132967 |
| 67 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.76740691 |
| 68 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.76727759 |
| 69 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.76131769 |
| 70 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.73919765 |
| 71 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.73618982 |
| 72 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.73484131 |
| 73 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.73052867 |
| 74 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.72892330 |
| 75 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.72545321 |
| 76 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.72328545 |
| 77 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.71818100 |
| 78 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.71765279 |
| 79 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.69927326 |
| 80 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.69924175 |
| 81 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.68470945 |
| 82 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.68258112 |
| 83 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.67780408 |
| 84 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.67753955 |
| 85 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.67391540 |
| 86 | TP53_16413492_ChIP-PET_HCT116_Human | 0.66947667 |
| 87 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.65556909 |
| 88 | SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.65423196 |
| 89 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.65020920 |
| 90 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.64845134 |
| 91 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.62842102 |
| 92 | VDR_22108803_ChIP-Seq_LS180_Human | 0.62831745 |
| 93 | AR_20517297_ChIP-Seq_VCAP_Human | 0.62637495 |
| 94 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.62294096 |
| 95 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.61995839 |
| 96 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.61580287 |
| 97 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.61255293 |
| 98 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.60638650 |
| 99 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.59685760 |
| 100 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.59393972 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003195_calcinosis | 7.77236812 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 7.03749911 |
| 3 | MP0005360_urolithiasis | 6.65771627 |
| 4 | MP0005365_abnormal_bile_salt | 4.84487304 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 4.58681048 |
| 6 | MP0004043_abnormal_pH_regulation | 4.27818672 |
| 7 | MP0002138_abnormal_hepatobiliary_system | 4.21315099 |
| 8 | MP0003252_abnormal_bile_duct | 3.75076311 |
| 9 | MP0008875_abnormal_xenobiotic_pharmacok | 3.67040714 |
| 10 | MP0001666_abnormal_nutrient_absorption | 3.31156707 |
| 11 | MP0010329_abnormal_lipoprotein_level | 3.02866257 |
| 12 | MP0004019_abnormal_vitamin_homeostasis | 2.71135183 |
| 13 | MP0005332_abnormal_amino_acid | 2.70007551 |
| 14 | MP0009840_abnormal_foam_cell | 2.33392436 |
| 15 | MP0001756_abnormal_urination | 2.15250745 |
| 16 | MP0000566_synostosis | 2.12460050 |
| 17 | MP0009643_abnormal_urine_homeostasis | 2.01078135 |
| 18 | MP0003283_abnormal_digestive_organ | 1.83875083 |
| 19 | MP0003868_abnormal_feces_composition | 1.83272405 |
| 20 | MP0005670_abnormal_white_adipose | 1.68754905 |
| 21 | MP0005636_abnormal_mineral_homeostasis | 1.65537806 |
| 22 | MP0002118_abnormal_lipid_homeostasis | 1.62363288 |
| 23 | MP0010368_abnormal_lymphatic_system | 1.56530901 |
| 24 | MP0001765_abnormal_ion_homeostasis | 1.47341879 |
| 25 | MP0000609_abnormal_liver_physiology | 1.41326992 |
| 26 | MP0003191_abnormal_cellular_cholesterol | 1.41156772 |
| 27 | MP0003122_maternal_imprinting | 1.39688620 |
| 28 | MP0004264_abnormal_extraembryonic_tissu | 1.25128357 |
| 29 | MP0002136_abnormal_kidney_physiology | 1.23938545 |
| 30 | MP0002876_abnormal_thyroid_physiology | 1.23365194 |
| 31 | MP0002168_other_aberrant_phenotype | 1.22397289 |
| 32 | MP0003879_abnormal_hair_cell | 1.19748420 |
| 33 | MP0001764_abnormal_homeostasis | 1.18871147 |
| 34 | MP0009697_abnormal_copulation | 1.09835916 |
| 35 | MP0002089_abnormal_postnatal_growth/wei | 1.04856371 |
| 36 | MP0002132_abnormal_respiratory_system | 1.01581120 |
| 37 | MP0001661_extended_life_span | 0.98310625 |
| 38 | MP0005220_abnormal_exocrine_pancreas | 0.96445587 |
| 39 | MP0005409_darkened_coat_color | 0.95422131 |
| 40 | MP0003183_abnormal_peptide_metabolism | 0.94302221 |
| 41 | MP0003878_abnormal_ear_physiology | 0.92984948 |
| 42 | MP0005377_hearing/vestibular/ear_phenot | 0.92984948 |
| 43 | MP0005395_other_phenotype | 0.92157680 |
| 44 | MP0005319_abnormal_enzyme/_coenzyme | 0.87533007 |
| 45 | MP0009642_abnormal_blood_homeostasis | 0.86140787 |
| 46 | MP0005408_hypopigmentation | 0.83092146 |
| 47 | MP0001270_distended_abdomen | 0.80645684 |
| 48 | MP0000598_abnormal_liver_morphology | 0.79228994 |
| 49 | MP0002928_abnormal_bile_duct | 0.76835352 |
| 50 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.74000927 |
| 51 | MP0003011_delayed_dark_adaptation | 0.73994978 |
| 52 | MP0005451_abnormal_body_composition | 0.73632088 |
| 53 | MP0002971_abnormal_brown_adipose | 0.73466464 |
| 54 | MP0005084_abnormal_gallbladder_morpholo | 0.70697786 |
| 55 | MP0005058_abnormal_lysosome_morphology | 0.70038784 |
| 56 | MP0003953_abnormal_hormone_level | 0.65145293 |
| 57 | MP0008961_abnormal_basal_metabolism | 0.64665425 |
| 58 | MP0002078_abnormal_glucose_homeostasis | 0.64307289 |
| 59 | MP0000538_abnormal_urinary_bladder | 0.63390617 |
| 60 | MP0008872_abnormal_physiological_respon | 0.63156204 |
| 61 | MP0002909_abnormal_adrenal_gland | 0.60784823 |
| 62 | MP0004272_abnormal_basement_membrane | 0.59645982 |
| 63 | MP0000604_amyloidosis | 0.59361685 |
| 64 | MP0005448_abnormal_energy_balance | 0.58949335 |
| 65 | MP0003943_abnormal_hepatobiliary_system | 0.58477700 |
| 66 | MP0002249_abnormal_larynx_morphology | 0.55922107 |
| 67 | MP0000678_abnormal_parathyroid_gland | 0.55867447 |
| 68 | MP0003123_paternal_imprinting | 0.55751613 |
| 69 | MP0000639_abnormal_adrenal_gland | 0.54138845 |
| 70 | MP0009384_cardiac_valve_regurgitation | 0.53140799 |
| 71 | MP0005083_abnormal_biliary_tract | 0.52228924 |
| 72 | MP0002282_abnormal_trachea_morphology | 0.52047834 |
| 73 | MP0002135_abnormal_kidney_morphology | 0.51971439 |
| 74 | MP0003567_abnormal_fetal_cardiomyocyte | 0.51690965 |
| 75 | MP0001915_intracranial_hemorrhage | 0.50317266 |
| 76 | MP0005666_abnormal_adipose_tissue | 0.47391199 |
| 77 | MP0000462_abnormal_digestive_system | 0.46891050 |
| 78 | MP0009115_abnormal_fat_cell | 0.46606361 |
| 79 | MP0009780_abnormal_chondrocyte_physiolo | 0.43686096 |
| 80 | MP0001664_abnormal_digestion | 0.41181162 |
| 81 | MP0005535_abnormal_body_temperature | 0.40759072 |
| 82 | MP0003172_abnormal_lysosome_physiology | 0.40538269 |
| 83 | MP0001944_abnormal_pancreas_morphology | 0.39824568 |
| 84 | MP0003941_abnormal_skin_development | 0.39779606 |
| 85 | MP0008004_abnormal_stomach_pH | 0.39500937 |
| 86 | MP0000230_abnormal_systemic_arterial | 0.38470206 |
| 87 | MP0005376_homeostasis/metabolism_phenot | 0.37408256 |
| 88 | MP0008469_abnormal_protein_level | 0.37133509 |
| 89 | MP0005334_abnormal_fat_pad | 0.37090919 |
| 90 | MP0003638_abnormal_response/metabolism_ | 0.35169974 |
| 91 | MP0000003_abnormal_adipose_tissue | 0.33884248 |
| 92 | MP0005551_abnormal_eye_electrophysiolog | 0.33431134 |
| 93 | MP0003115_abnormal_respiratory_system | 0.31737997 |
| 94 | MP0005375_adipose_tissue_phenotype | 0.31360052 |
| 95 | MP0003119_abnormal_digestive_system | 0.29008272 |
| 96 | MP0002092_abnormal_eye_morphology | 0.28912595 |
| 97 | MP0002896_abnormal_bone_mineralization | 0.28581879 |
| 98 | MP0004782_abnormal_surfactant_physiolog | 0.28296375 |
| 99 | MP0002069_abnormal_eating/drinking_beha | 0.27967905 |
| 100 | MP0006054_spinal_hemorrhage | 0.26666788 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.17878874 |
| 2 | Metabolic alkalosis (HP:0200114) | 6.97696325 |
| 3 | Increased circulating renin level (HP:0000848) | 6.91639060 |
| 4 | Hyperactive renin-angiotensin system (HP:0000841) | 6.38442459 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.11384711 |
| 6 | Complement deficiency (HP:0004431) | 5.95249936 |
| 7 | Hypokalemic alkalosis (HP:0001949) | 5.68835044 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 5.56197693 |
| 9 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.51565510 |
| 10 | Abnormality of chloride homeostasis (HP:0011422) | 5.36574705 |
| 11 | Joint hemorrhage (HP:0005261) | 5.05233518 |
| 12 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.91752381 |
| 13 | Hypomagnesemia (HP:0002917) | 4.85788885 |
| 14 | Abnormality of complement system (HP:0005339) | 4.61678556 |
| 15 | Hyperaldosteronism (HP:0000859) | 4.61549543 |
| 16 | Alkalosis (HP:0001948) | 4.47132970 |
| 17 | Xanthomatosis (HP:0000991) | 4.44068531 |
| 18 | Gout (HP:0001997) | 4.24656549 |
| 19 | Systemic lupus erythematosus (HP:0002725) | 4.19336416 |
| 20 | Abnormality of magnesium homeostasis (HP:0004921) | 4.13379518 |
| 21 | Renal salt wasting (HP:0000127) | 4.11286774 |
| 22 | Abnormality of renin-angiotensin system (HP:0000847) | 4.09753755 |
| 23 | Abnormal urine output (HP:0012590) | 3.92765725 |
| 24 | Polyuria (HP:0000103) | 3.77514290 |
| 25 | Glomerulonephritis (HP:0000099) | 3.71867979 |
| 26 | Abnormality of renal excretion (HP:0011036) | 3.63277962 |
| 27 | Hyperlipoproteinemia (HP:0010980) | 3.61735327 |
| 28 | Hypokalemia (HP:0002900) | 3.53419566 |
| 29 | Hypolipoproteinemia (HP:0010981) | 3.46773619 |
| 30 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.44757891 |
| 31 | Spontaneous abortion (HP:0005268) | 3.41313543 |
| 32 | Proximal tubulopathy (HP:0000114) | 3.38033694 |
| 33 | Tetany (HP:0001281) | 3.26512491 |
| 34 | Generalized aminoaciduria (HP:0002909) | 3.24718638 |
| 35 | Abnormality of the common coagulation pathway (HP:0010990) | 3.15528581 |
| 36 | Potter facies (HP:0002009) | 3.15484522 |
| 37 | Facial shape deformation (HP:0011334) | 3.15484522 |
| 38 | Conjugated hyperbilirubinemia (HP:0002908) | 3.10689928 |
| 39 | Intrahepatic cholestasis (HP:0001406) | 3.08144321 |
| 40 | Hemorrhage of the eye (HP:0011885) | 3.05949277 |
| 41 | Abnormality of potassium homeostasis (HP:0011042) | 2.93371255 |
| 42 | Vascular calcification (HP:0004934) | 2.85284172 |
| 43 | Rickets (HP:0002748) | 2.84047871 |
| 44 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.80148846 |
| 45 | Enlarged kidneys (HP:0000105) | 2.73142576 |
| 46 | Hypercholesterolemia (HP:0003124) | 2.65078654 |
| 47 | Hypercalciuria (HP:0002150) | 2.64891915 |
| 48 | Hypoalphalipoproteinemia (HP:0003233) | 2.60946519 |
| 49 | Osteomalacia (HP:0002749) | 2.60797993 |
| 50 | Hyperphosphaturia (HP:0003109) | 2.57019532 |
| 51 | Glycosuria (HP:0003076) | 2.56889936 |
| 52 | Abnormality of urine glucose concentration (HP:0011016) | 2.56889936 |
| 53 | Abnormality of purine metabolism (HP:0004352) | 2.55904280 |
| 54 | Abnormality of nucleobase metabolism (HP:0010932) | 2.54343562 |
| 55 | Fat malabsorption (HP:0002630) | 2.54037896 |
| 56 | Polydipsia (HP:0001959) | 2.53086634 |
| 57 | Abnormal drinking behavior (HP:0030082) | 2.53086634 |
| 58 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.50938359 |
| 59 | Nephritis (HP:0000123) | 2.49764922 |
| 60 | Epidermoid cyst (HP:0200040) | 2.49560744 |
| 61 | Hypophosphatemic rickets (HP:0004912) | 2.49192551 |
| 62 | Abnormality of glycine metabolism (HP:0010895) | 2.48967361 |
| 63 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.48967361 |
| 64 | Cardiovascular calcification (HP:0011915) | 2.45655699 |
| 65 | Hyperglycinemia (HP:0002154) | 2.44659859 |
| 66 | Abnormality of carpal bone ossification (HP:0006257) | 2.41256169 |
| 67 | Hyperglycinuria (HP:0003108) | 2.41224903 |
| 68 | Abnormal urine phosphate concentration (HP:0012599) | 2.37655617 |
| 69 | Abnormality of proline metabolism (HP:0010907) | 2.37020921 |
| 70 | Hydroxyprolinuria (HP:0003080) | 2.37020921 |
| 71 | Hyperuricemia (HP:0002149) | 2.33643538 |
| 72 | Increased purine levels (HP:0004368) | 2.33643538 |
| 73 | Hypotension (HP:0002615) | 2.27482257 |
| 74 | Menorrhagia (HP:0000132) | 2.27321010 |
| 75 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.24698565 |
| 76 | Adrenal overactivity (HP:0002717) | 2.15499505 |
| 77 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.14645670 |
| 78 | Abnormality of the intrinsic pathway (HP:0010989) | 2.14374550 |
| 79 | Delayed CNS myelination (HP:0002188) | 2.10011108 |
| 80 | Abnormality of sodium homeostasis (HP:0010931) | 2.07970396 |
| 81 | Chondrocalcinosis (HP:0000934) | 2.06257438 |
| 82 | Focal segmental glomerulosclerosis (HP:0000097) | 2.06144168 |
| 83 | Abnormal tarsal ossification (HP:0008369) | 2.05758537 |
| 84 | Abnormality of Sharpey fibers (HP:0100685) | 2.05556694 |
| 85 | Gingival bleeding (HP:0000225) | 2.04873744 |
| 86 | Hypophosphatemia (HP:0002148) | 2.01491516 |
| 87 | Mitral stenosis (HP:0001718) | 2.01465005 |
| 88 | Abnormality of vitamin metabolism (HP:0100508) | 1.98538100 |
| 89 | Nephrocalcinosis (HP:0000121) | 1.92412618 |
| 90 | Pigmentary retinal degeneration (HP:0001146) | 1.90341033 |
| 91 | Hyponatremia (HP:0002902) | 1.88731698 |
| 92 | Glomerulosclerosis (HP:0000096) | 1.86150862 |
| 93 | Hyperammonemia (HP:0001987) | 1.83698632 |
| 94 | Nephrolithiasis (HP:0000787) | 1.83401634 |
| 95 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.82129066 |
| 96 | Abnormal hand bone ossification (HP:0010660) | 1.80113908 |
| 97 | Megaloblastic anemia (HP:0001889) | 1.79603625 |
| 98 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.79587314 |
| 99 | Thrombophlebitis (HP:0004418) | 1.78917396 |
| 100 | Neonatal death (HP:0003811) | 1.78383427 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK3 | 8.78454188 |
| 2 | OXSR1 | 6.51411786 |
| 3 | WNK4 | 4.64642367 |
| 4 | FGFR4 | 3.93710858 |
| 5 | STK39 | 2.87446993 |
| 6 | LATS1 | 2.60538088 |
| 7 | FGFR3 | 2.32622247 |
| 8 | ERN1 | 2.17426953 |
| 9 | FGFR2 | 1.98546874 |
| 10 | SGK2 | 1.90530623 |
| 11 | RIPK1 | 1.89272577 |
| 12 | SGK223 | 1.66260134 |
| 13 | SGK494 | 1.66260134 |
| 14 | MST1R | 1.58493746 |
| 15 | SGK3 | 1.52946489 |
| 16 | EPHA2 | 1.51396343 |
| 17 | ACVR1B | 1.45354781 |
| 18 | MET | 1.44819287 |
| 19 | ICK | 1.44474042 |
| 20 | LMTK2 | 1.38191842 |
| 21 | PIK3CA | 1.30747006 |
| 22 | FRK | 1.29915911 |
| 23 | PDK2 | 1.24386527 |
| 24 | PRKAA2 | 1.19380372 |
| 25 | TYRO3 | 1.07450246 |
| 26 | AKT3 | 1.04082699 |
| 27 | FGFR1 | 0.99922701 |
| 28 | TRIB3 | 0.99847132 |
| 29 | NLK | 0.98565312 |
| 30 | MAP3K2 | 0.95738315 |
| 31 | MAP3K7 | 0.94901087 |
| 32 | WNK1 | 0.93952482 |
| 33 | CDK12 | 0.88932183 |
| 34 | NTRK3 | 0.88493973 |
| 35 | PRKAA1 | 0.87754686 |
| 36 | PDGFRA | 0.86371257 |
| 37 | EPHA4 | 0.85049230 |
| 38 | DDR2 | 0.80965304 |
| 39 | GRK1 | 0.80754804 |
| 40 | DYRK1B | 0.80630972 |
| 41 | SIK1 | 0.80516695 |
| 42 | ERBB2 | 0.77382143 |
| 43 | PDPK1 | 0.71251947 |
| 44 | PIK3CG | 0.68467914 |
| 45 | RET | 0.65128060 |
| 46 | INSRR | 0.64142950 |
| 47 | SGK1 | 0.63879125 |
| 48 | PRKACG | 0.62832584 |
| 49 | BRSK2 | 0.62564275 |
| 50 | CAMKK2 | 0.62031790 |
| 51 | MELK | 0.55903993 |
| 52 | PRKG2 | 0.51445347 |
| 53 | MAPK11 | 0.51398638 |
| 54 | PDGFRB | 0.50409988 |
| 55 | CSF1R | 0.49992867 |
| 56 | DAPK2 | 0.48719944 |
| 57 | MAP2K6 | 0.47820803 |
| 58 | FGR | 0.47111621 |
| 59 | PTK6 | 0.47049306 |
| 60 | PDK1 | 0.45786699 |
| 61 | CASK | 0.45043219 |
| 62 | BCR | 0.43997027 |
| 63 | NEK2 | 0.43512255 |
| 64 | CAMK1G | 0.42121369 |
| 65 | PRKCG | 0.41764116 |
| 66 | PRPF4B | 0.40758829 |
| 67 | CAMK1D | 0.38700629 |
| 68 | STK38L | 0.36402273 |
| 69 | STK3 | 0.36025438 |
| 70 | PRKCZ | 0.35927285 |
| 71 | MAP2K2 | 0.35644476 |
| 72 | BMX | 0.35009325 |
| 73 | PKN2 | 0.32260382 |
| 74 | MUSK | 0.31421587 |
| 75 | NUAK1 | 0.30583066 |
| 76 | CSNK1A1 | 0.29152542 |
| 77 | STK38 | 0.29068873 |
| 78 | PRKG1 | 0.29039979 |
| 79 | PRKACA | 0.25796128 |
| 80 | CSNK1E | 0.25652650 |
| 81 | CDK4 | 0.25146186 |
| 82 | SRC | 0.25009419 |
| 83 | MAP2K4 | 0.24122085 |
| 84 | PNCK | 0.24042907 |
| 85 | CDC42BPA | 0.23675660 |
| 86 | CDK7 | 0.23571306 |
| 87 | RPS6KB1 | 0.21657880 |
| 88 | IGF1R | 0.20750003 |
| 89 | PTK2 | 0.19829957 |
| 90 | MYLK | 0.19552270 |
| 91 | STK11 | 0.19475193 |
| 92 | MAP3K1 | 0.19345654 |
| 93 | RPS6KA3 | 0.19163343 |
| 94 | MAPK15 | 0.19042560 |
| 95 | TYK2 | 0.18622456 |
| 96 | DYRK1A | 0.16921124 |
| 97 | MARK2 | 0.15993101 |
| 98 | CDK3 | 0.15991037 |
| 99 | MATK | 0.15905372 |
| 100 | PRKACB | 0.14680467 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 4.06747772 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.40773924 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.24881537 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.96814292 |
| 5 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.81213211 |
| 6 | Retinol metabolism_Homo sapiens_hsa00830 | 2.71787829 |
| 7 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.70175354 |
| 8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.56119414 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.56070510 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.54632271 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.51177085 |
| 12 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.49503096 |
| 13 | Histidine metabolism_Homo sapiens_hsa00340 | 2.44310558 |
| 14 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.37072274 |
| 15 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.30253018 |
| 16 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.29745791 |
| 17 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.23835605 |
| 18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.23789120 |
| 19 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.16378858 |
| 20 | Bile secretion_Homo sapiens_hsa04976 | 2.03516684 |
| 21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.96095128 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.86911353 |
| 23 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.85525165 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.84550746 |
| 25 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.79382807 |
| 26 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.77696163 |
| 27 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.72896957 |
| 28 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.64125457 |
| 29 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.64083578 |
| 30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.57128279 |
| 31 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.52089682 |
| 32 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.44184686 |
| 33 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.43518879 |
| 34 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.34084048 |
| 35 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.21764048 |
| 36 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.19548295 |
| 37 | ABC transporters_Homo sapiens_hsa02010 | 1.17049054 |
| 38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.16215079 |
| 39 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.12128110 |
| 40 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.11298621 |
| 41 | Peroxisome_Homo sapiens_hsa04146 | 1.10117544 |
| 42 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.07329927 |
| 43 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.06083392 |
| 44 | Mineral absorption_Homo sapiens_hsa04978 | 1.03506536 |
| 45 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.01636071 |
| 46 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.00783311 |
| 47 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.93841920 |
| 48 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.93374826 |
| 49 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.86231615 |
| 50 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.85711192 |
| 51 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.84783347 |
| 52 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.83533388 |
| 53 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.80750135 |
| 54 | Other glycan degradation_Homo sapiens_hsa00511 | 0.80636511 |
| 55 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.78015554 |
| 56 | Prion diseases_Homo sapiens_hsa05020 | 0.76587327 |
| 57 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.75875099 |
| 58 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.69698137 |
| 59 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.69457264 |
| 60 | Lysine degradation_Homo sapiens_hsa00310 | 0.67731950 |
| 61 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.66319020 |
| 62 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.65108082 |
| 63 | Carbon metabolism_Homo sapiens_hsa01200 | 0.58675616 |
| 64 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.55952982 |
| 65 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.53855261 |
| 66 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.52128090 |
| 67 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.52042360 |
| 68 | Sulfur relay system_Homo sapiens_hsa04122 | 0.49008656 |
| 69 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.47766898 |
| 70 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.47527904 |
| 71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.47092171 |
| 72 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.44669386 |
| 73 | Metabolic pathways_Homo sapiens_hsa01100 | 0.42230801 |
| 74 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.41265405 |
| 75 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.37203978 |
| 76 | Insulin resistance_Homo sapiens_hsa04931 | 0.36775826 |
| 77 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.32012031 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.31438209 |
| 79 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.29975415 |
| 80 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.29140600 |
| 81 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.27609342 |
| 82 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.27343420 |
| 83 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.26906218 |
| 84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.24470899 |
| 85 | Pertussis_Homo sapiens_hsa05133 | 0.22063721 |
| 86 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.21460154 |
| 87 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.20279787 |
| 88 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.10120544 |
| 89 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.09896239 |
| 90 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.07259159 |
| 91 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.06870535 |
| 92 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.05124542 |
| 93 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.03456219 |
| 94 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.01458060 |
| 95 | Circadian rhythm_Homo sapiens_hsa04710 | 0.00412764 |
| 96 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | -0.0920591 |
| 97 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0795040 |
| 98 | Choline metabolism in cancer_Homo sapiens_hsa05231 | -0.0267783 |
| 99 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | -0.0171423 |
| 100 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0045981 |

